nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—Ischaemic stroke—Ramipril—type 1 diabetes mellitus	0.125	0.176	CcSEcCtD
Naltrexone—Depressed mood—Ramipril—type 1 diabetes mellitus	0.0321	0.0454	CcSEcCtD
Naltrexone—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.0166	0.0234	CcSEcCtD
Naltrexone—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.0121	0.017	CcSEcCtD
Naltrexone—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0118	0.0166	CcSEcCtD
Naltrexone—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.0115	0.0162	CcSEcCtD
Naltrexone—Libido decreased—Ramipril—type 1 diabetes mellitus	0.0112	0.0159	CcSEcCtD
Naltrexone—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.011	0.0155	CcSEcCtD
Naltrexone—Purpura—Ramipril—type 1 diabetes mellitus	0.0108	0.0153	CcSEcCtD
Naltrexone—Arthritis—Ramipril—type 1 diabetes mellitus	0.0107	0.0152	CcSEcCtD
Naltrexone—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.0103	0.0146	CcSEcCtD
Naltrexone—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00953	0.0135	CcSEcCtD
Naltrexone—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00939	0.0133	CcSEcCtD
Naltrexone—Influenza—Ramipril—type 1 diabetes mellitus	0.00902	0.0127	CcSEcCtD
Naltrexone—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00878	0.0124	CcSEcCtD
Naltrexone—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00878	0.0124	CcSEcCtD
Naltrexone—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00867	0.0122	CcSEcCtD
Naltrexone—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00864	0.0122	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00838	0.0118	CcSEcCtD
Naltrexone—Weight increased—Ramipril—type 1 diabetes mellitus	0.00821	0.0116	CcSEcCtD
Naltrexone—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00792	0.0112	CcSEcCtD
Naltrexone—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00788	0.0111	CcSEcCtD
Naltrexone—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00781	0.011	CcSEcCtD
Naltrexone—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00781	0.011	CcSEcCtD
Naltrexone—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.0076	0.0107	CcSEcCtD
Naltrexone—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00758	0.0107	CcSEcCtD
Naltrexone—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00754	0.0106	CcSEcCtD
Naltrexone—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00722	0.0102	CcSEcCtD
Naltrexone—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00709	0.01	CcSEcCtD
Naltrexone—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00673	0.0095	CcSEcCtD
Naltrexone—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00652	0.0092	CcSEcCtD
Naltrexone—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.0065	0.00918	CcSEcCtD
Naltrexone—Alopecia—Ramipril—type 1 diabetes mellitus	0.00638	0.009	CcSEcCtD
Naltrexone—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00632	0.00893	CcSEcCtD
Naltrexone—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00628	0.00887	CcSEcCtD
Naltrexone—Tension—Ramipril—type 1 diabetes mellitus	0.00616	0.0087	CcSEcCtD
Naltrexone—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00615	0.00869	CcSEcCtD
Naltrexone—Nervousness—Ramipril—type 1 diabetes mellitus	0.0061	0.00861	CcSEcCtD
Naltrexone—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00604	0.00853	CcSEcCtD
Naltrexone—Tremor—Ramipril—type 1 diabetes mellitus	0.00589	0.00831	CcSEcCtD
Naltrexone—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00583	0.00823	CcSEcCtD
Naltrexone—Agitation—Ramipril—type 1 diabetes mellitus	0.00577	0.00815	CcSEcCtD
Naltrexone—Angioedema—Ramipril—type 1 diabetes mellitus	0.00574	0.0081	CcSEcCtD
Naltrexone—Malaise—Ramipril—type 1 diabetes mellitus	0.00567	0.008	CcSEcCtD
Naltrexone—Syncope—Ramipril—type 1 diabetes mellitus	0.00563	0.00795	CcSEcCtD
Naltrexone—Palpitations—Ramipril—type 1 diabetes mellitus	0.00555	0.00784	CcSEcCtD
Naltrexone—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00552	0.0078	CcSEcCtD
Naltrexone—Cough—Ramipril—type 1 diabetes mellitus	0.00548	0.00774	CcSEcCtD
Naltrexone—Convulsion—Ramipril—type 1 diabetes mellitus	0.00544	0.00768	CcSEcCtD
Naltrexone—Chest pain—Ramipril—type 1 diabetes mellitus	0.00535	0.00755	CcSEcCtD
Naltrexone—Myalgia—Ramipril—type 1 diabetes mellitus	0.00535	0.00755	CcSEcCtD
Naltrexone—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00535	0.00755	CcSEcCtD
Naltrexone—Anxiety—Ramipril—type 1 diabetes mellitus	0.00533	0.00753	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00531	0.0075	CcSEcCtD
Naltrexone—Discomfort—Ramipril—type 1 diabetes mellitus	0.00528	0.00746	CcSEcCtD
Naltrexone—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00523	0.00739	CcSEcCtD
Naltrexone—Confusional state—Ramipril—type 1 diabetes mellitus	0.00517	0.0073	CcSEcCtD
Naltrexone—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00513	0.00724	CcSEcCtD
Naltrexone—Oedema—Ramipril—type 1 diabetes mellitus	0.00513	0.00724	CcSEcCtD
Naltrexone—Shock—Ramipril—type 1 diabetes mellitus	0.00504	0.00712	CcSEcCtD
Naltrexone—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00503	0.0071	CcSEcCtD
Naltrexone—Tachycardia—Ramipril—type 1 diabetes mellitus	0.005	0.00706	CcSEcCtD
Naltrexone—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00498	0.00703	CcSEcCtD
Naltrexone—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00496	0.007	CcSEcCtD
Naltrexone—Anorexia—Ramipril—type 1 diabetes mellitus	0.00489	0.0069	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00467	0.0066	CcSEcCtD
Naltrexone—Insomnia—Ramipril—type 1 diabetes mellitus	0.00464	0.00655	CcSEcCtD
Naltrexone—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.0046	0.0065	CcSEcCtD
Naltrexone—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00457	0.00645	CcSEcCtD
Naltrexone—Somnolence—Ramipril—type 1 diabetes mellitus	0.00456	0.00644	CcSEcCtD
Naltrexone—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00446	0.00629	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00443	0.00625	CcSEcCtD
Naltrexone—Fatigue—Ramipril—type 1 diabetes mellitus	0.00442	0.00624	CcSEcCtD
Naltrexone—Constipation—Ramipril—type 1 diabetes mellitus	0.00438	0.00619	CcSEcCtD
Naltrexone—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00422	0.00597	CcSEcCtD
Naltrexone—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00419	0.00592	CcSEcCtD
Naltrexone—Urticaria—Ramipril—type 1 diabetes mellitus	0.00407	0.00575	CcSEcCtD
Naltrexone—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00405	0.00572	CcSEcCtD
Naltrexone—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00405	0.00572	CcSEcCtD
Naltrexone—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00378	0.00533	CcSEcCtD
Naltrexone—Asthenia—Ramipril—type 1 diabetes mellitus	0.00368	0.00519	CcSEcCtD
Naltrexone—Pruritus—Ramipril—type 1 diabetes mellitus	0.00363	0.00512	CcSEcCtD
Naltrexone—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00351	0.00495	CcSEcCtD
Naltrexone—Dizziness—Ramipril—type 1 diabetes mellitus	0.00339	0.00479	CcSEcCtD
Naltrexone—Vomiting—Ramipril—type 1 diabetes mellitus	0.00326	0.0046	CcSEcCtD
Naltrexone—Rash—Ramipril—type 1 diabetes mellitus	0.00323	0.00456	CcSEcCtD
Naltrexone—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00323	0.00456	CcSEcCtD
Naltrexone—Headache—Ramipril—type 1 diabetes mellitus	0.00321	0.00453	CcSEcCtD
Naltrexone—Nausea—Ramipril—type 1 diabetes mellitus	0.00305	0.0043	CcSEcCtD
Naltrexone—OPRM1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.000758	0.0026	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000746	0.00256	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00074	0.00254	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000732	0.00251	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.000726	0.00249	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.000708	0.00243	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.000707	0.00242	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000702	0.0024	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.000693	0.00238	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000688	0.00236	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000672	0.0023	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000666	0.00228	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.000665	0.00228	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000665	0.00228	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000665	0.00228	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.000662	0.00227	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.000657	0.00225	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000654	0.00224	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—CD80—type 1 diabetes mellitus	0.000653	0.00224	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000649	0.00222	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000642	0.0022	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000625	0.00214	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000618	0.00212	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000603	0.00207	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000593	0.00203	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000589	0.00202	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000583	0.002	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000583	0.002	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000578	0.00198	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000578	0.00198	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000563	0.00193	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000561	0.00192	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000553	0.00189	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—HBA2—type 1 diabetes mellitus	0.000552	0.00189	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000548	0.00188	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000548	0.00188	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000542	0.00186	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000542	0.00186	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000525	0.0018	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000519	0.00178	CbGpPWpGaD
Naltrexone—OPRM1—TCR Signaling Pathway—IL6—type 1 diabetes mellitus	0.000518	0.00178	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.000517	0.00177	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00051	0.00175	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000508	0.00174	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000507	0.00174	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000507	0.00174	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000507	0.00174	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000505	0.00173	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000498	0.00171	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000492	0.00169	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000492	0.00169	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000492	0.00169	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000463	0.00159	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.000461	0.00158	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000461	0.00158	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00046	0.00158	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.00046	0.00158	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.000459	0.00157	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000459	0.00157	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000458	0.00157	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000452	0.00155	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ABCC8—type 1 diabetes mellitus	0.00045	0.00154	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000445	0.00152	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000443	0.00152	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000441	0.00151	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000435	0.00149	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000429	0.00147	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000428	0.00147	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000423	0.00145	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000421	0.00144	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000419	0.00144	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000416	0.00142	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000411	0.00141	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000404	0.00138	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000403	0.00138	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000402	0.00138	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000397	0.00136	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000396	0.00136	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000395	0.00135	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000393	0.00135	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000393	0.00135	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000389	0.00133	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000384	0.00132	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000383	0.00131	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000382	0.00131	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000376	0.00129	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000374	0.00128	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000371	0.00127	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00037	0.00127	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000369	0.00127	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00036	0.00123	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000356	0.00122	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000348	0.00119	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000347	0.00119	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000344	0.00118	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000344	0.00118	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000342	0.00117	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000341	0.00117	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00034	0.00116	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000338	0.00116	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000337	0.00115	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000336	0.00115	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000335	0.00115	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.000334	0.00115	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000331	0.00114	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000327	0.00112	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000324	0.00111	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000323	0.00111	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000322	0.0011	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000313	0.00107	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000312	0.00107	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000312	0.00107	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000311	0.00106	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00031	0.00106	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00031	0.00106	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000308	0.00106	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000304	0.00104	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ITPR3—type 1 diabetes mellitus	0.0003	0.00103	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000297	0.00102	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000295	0.00101	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000294	0.00101	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000293	0.001	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000293	0.001	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000291	0.000997	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000291	0.000997	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000291	0.000996	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000287	0.000982	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000284	0.000975	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000284	0.000972	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—HBA1—type 1 diabetes mellitus	0.000283	0.000969	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000282	0.000968	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—APOC3—type 1 diabetes mellitus	0.000281	0.000963	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000276	0.000946	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000274	0.000938	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000273	0.000937	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000272	0.000933	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000272	0.000932	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000272	0.000932	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000271	0.000929	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00026	0.000892	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000257	0.000879	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000253	0.000868	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000246	0.000842	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000243	0.000831	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000242	0.00083	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000239	0.000818	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000239	0.000818	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000238	0.000816	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000238	0.000814	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000233	0.0008	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000231	0.000792	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00023	0.000787	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00023	0.000787	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000227	0.000778	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000227	0.000777	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000226	0.000775	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00022	0.000754	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GCG—type 1 diabetes mellitus	0.00022	0.000753	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000217	0.000743	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000213	0.000729	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000206	0.000708	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000206	0.000706	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000205	0.000704	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000205	0.000702	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000202	0.000691	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000201	0.000688	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000199	0.000681	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000198	0.00068	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000198	0.000678	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000189	0.000647	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000188	0.000643	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CAT—type 1 diabetes mellitus	0.000186	0.000638	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000181	0.000619	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00018	0.000617	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00018	0.000616	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000178	0.000611	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000175	0.000601	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000173	0.000594	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000173	0.000594	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000173	0.000593	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000173	0.000592	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000172	0.000588	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000168	0.000576	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000168	0.000574	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000166	0.000568	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000165	0.000566	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000165	0.000564	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000163	0.000559	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000156	0.000536	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000154	0.000527	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000153	0.000524	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000152	0.000522	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000152	0.000519	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.00015	0.000515	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000147	0.000502	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000144	0.000494	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00014	0.00048	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000139	0.000477	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000138	0.000472	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000136	0.000467	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000132	0.000453	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000132	0.000452	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000131	0.00045	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00013	0.000445	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	0.00013	0.000444	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	0.000129	0.000442	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000128	0.000439	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000127	0.000436	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000127	0.000434	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000126	0.000434	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—INS—type 1 diabetes mellitus	0.000124	0.000423	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000122	0.000417	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.00012	0.00041	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000119	0.00041	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000116	0.000396	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000115	0.000394	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ALB—type 1 diabetes mellitus	0.000113	0.000388	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000111	0.00038	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NOS3—type 1 diabetes mellitus	0.000108	0.000371	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000107	0.000366	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000107	0.000366	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000105	0.000359	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000101	0.000348	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000101	0.000347	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000101	0.000346	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	0.000101	0.000346	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000101	0.000346	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.77e-05	0.000335	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.72e-05	0.000333	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.02e-05	0.000309	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.9e-05	0.000305	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	8.88e-05	0.000305	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.86e-05	0.000304	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.84e-05	0.000303	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	8.54e-05	0.000293	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.53e-05	0.000292	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.75e-05	0.000266	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.52e-05	0.000258	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	7.51e-05	0.000257	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.48e-05	0.000256	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.47e-05	0.000256	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.79e-05	0.000233	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.32e-05	0.000217	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.95e-05	0.000204	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.74e-05	0.000197	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—INS—type 1 diabetes mellitus	5.67e-05	0.000194	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.22e-05	0.000179	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	5.19e-05	0.000178	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	4.97e-05	0.00017	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.41e-05	0.000151	CbGpPWpGaD
